Laminariae thalli (seaweed)

Ukraine
Brand name Laminariae thalli (seaweed)
Form saline solution, oral
Active substance / Dosage
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/7579/01/01
Manufacturer PJSC "Lektravy"
Laminariae thalli (seaweed) saline solution, oral

I N S T R U C T I O N for medical use of the medicinal product LAMINARIAE THALLI (SEA KELP) (LAMINARIAE THALLI)

Composition:

Active substance: Laminariae thalli.

Pharmaceutical form. Thalli.

Main physicochemical properties: pieces of thalli of various shapes, from light olive to dark olive, greenish-brown, reddish-brown, dark grey with a greenish tint, greenish-black in colour, externally covered with a white efflorescence of salts.

Pharmacotherapeutic group. Laxatives. ATC code A06AC.

Pharmacological Properties.

Pharmacodynamics.

The biologically active substances of the drug exert anti-inflammatory, diuretic, general tonic, anti-sclerotic, and hypoglycemic effects; actively influence the function of the thyroid gland; regulate metabolism; promote bowel evacuation; and facilitate the excretion of radionuclides from the body.

Clinical characteristics.

Indications.

Chronic atonic constipation; chronic enterocolitis, proctitis – as part of complex therapy; mild forms of diffuse toxic goiter (Graves' disease) – as part of complex therapy; prevention of endemic goiter and atherosclerosis; as an additional agent in hyperthyroidism.

Contraindications.

Hypersensitivity to biologically active substances of the drug or to iodine-containing preparations. Increased sensitivity to seaweed. Predisposition to bleeding, nephritis, hemorrhagic diatheses, furunculosis, pulmonary tuberculosis.

Interaction with other medicinal products and other forms of interactions. Not established.

Special precautions.

Use during pregnancy or breastfeeding. Contraindicated.

Ability to affect reaction speed when driving or operating machinery. Not established.

Method of administration and dosage.

For adults, take ½–1 teaspoon of seaweed in the morning or evening, accompanied by ⅓–½ glass of water.

For thyroid dysfunction, the treatment course lasts 15–30 days; in other cases, the duration of treatment is determined individually by a physician.

Children. There is no experience with the use of the drug in children.

Overdose. No reports available.

Side effects.

Hypersensitivity reactions. With prolonged use and increased sensitivity to iodine, symptoms of iodism are possible (rhinitis, lacrimation, hypersalivation). If adverse reactions occur, discontinue use of the product and consult a physician.

Shelf life. 3 years.

Do not use the product after the expiry date stated on the packaging.

Storage conditions. In the original packaging, in a place inaccessible to children, at a temperature not exceeding 30 °C.

Packaging. 75 g, 100 g, or 150 g in cartons with an inner packet.

Availability. Over-the-counter (without prescription).

Manufacturer/Applicant. JSC "Liktravy".

Address of manufacturer and location of business activity / address of applicant.

21, Kyivske Shose, Zhytomyr, Zhytomyr region, 10001, Ukraine.